Nearly 300 Vaccines in Development to Treat a Wide Variety of Diseases
America's biopharmaceutical research companies are developing nearly 300 vaccines that target diseases ranging from pancreatic cancer to HIV. Read more

New Tufts Report Shows Academic-Industry Partnersips Are Mutually Beneficial
New Tufts report takes a detailed look into the nature of partnerships between biopharmaceutical companies and academic medical centers. Read more

Alzheimer's Disease Affects 5.4 Million Americans
According to the Alzheimer's Association, as many as 5.4 million people are living with Alzheimer's disease in the United States. Innovation.org spotlights the pressing need for effective treatments for this devastating disease. Read more

Innovation.org Highlights the Far-Reaching Impact of Biopharmaceutical Innovation
This issue of Innovation Insights highlights the progress we have made in the fight against diseases from asthma to HIV/AIDS, and notes the steady climb in life expectancy in the U.S. over the last half century. Medicines are an important part of this progress. Read more